학술논문

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics
Document Type
Article
Source
In: American Heart Journal. (American Heart Journal, January 2024, 267:1-11)
Subject
Language
English
ISSN
10976744
00028703